Home/Filings/4/0001225208-20-008821
4//SEC Filing

GARNER DENISE 4

Accession 0001225208-20-008821

CIK 0000021076other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 7:42 PM ET

Size

26.9 KB

Accession

0001225208-20-008821

Insider Transaction Report

Form 4
Period: 2020-06-08
GARNER DENISE
SVP - Chief Innovation Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-06-08$111.60/sh+3,803$424,41529,461 total
  • Sale

    Common Stock

    2020-06-08$194.13/sh233$45,23332,588 total
  • Sale

    Common Stock

    2020-06-08$195.77/sh2,379$465,73830,209 total
  • Sale

    Common Stock

    2020-06-08$198.59/sh6,671$1,324,82316,969 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-06-083,36010,080 total
    Exercise: $151.85From: 2019-09-18Exp: 2028-09-18Common Stock (3,360 underlying)
  • Exercise/Conversion

    Common Stock

    2020-06-08$123.09/sh+11,602$1,428,09017,468 total
  • Sale

    Common Stock

    2020-06-08$196.74/sh6,569$1,292,40123,640 total
  • Sale

    Common Stock

    2020-06-08$198.06/sh9,980$1,976,6866,989 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-06-088,1908,190 total
    Exercise: $135.57From: 2018-09-12Exp: 2027-09-12Common Stock (8,190 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-06-0811,6023,868 total
    Exercise: $123.09From: 2017-09-13Exp: 2026-09-13Common Stock (11,602 underlying)
  • Exercise/Conversion

    Common Stock

    2020-06-08$135.57/sh+8,190$1,110,31825,658 total
  • Exercise/Conversion

    Common Stock

    2020-06-08$151.85/sh+3,360$510,21632,821 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-06-083,8030 total
    Exercise: $111.60From: 2016-09-15Exp: 2025-09-15Common Stock (3,803 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    2,178
Footnotes (6)
  • [F1]Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.
  • [F2]This transaction was executed in multiple trades at prices ranging from $194.00 to $194.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $195.24 to $196.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $196.27 to $197.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $198.33 to $198.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $197.31 to $198.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

CLOROX CO /DE/

CIK 0000021076

Entity typeother

Related Parties

1
  • filerCIK 0001629867

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:42 PM ET
Size
26.9 KB